Psychotropic dose equivalence in Japan.

Area of Science:

• Psychopharmacology
• Clinical Pharmacology
• Drug Development

Background:

• Psychotropic dose equivalence is crucial for accurate medication management and research.
• Standardized tables facilitate dose adjustments when switching medications and defining patient subgroups.
• Existing tables may not fully account for regional differences in psychopharmacological practices.

Purpose of the Study:

• To introduce updated psychotropic dose equivalency tables specifically designed for the Japanese population.
• To provide a unified reference for comparing various psychotropic agents.
• To aid clinicians and researchers in Japan with medication management and study design.

Main Methods:

• Compilation of dose equivalency tables for antipsychotics, antiparkinsonian agents, antidepressants, and anxiolytics/sedatives/hypnotics.
• Determination of equivalent doses based on randomized controlled trials conducted in Japan.
• Consensus building among psychopharmacological experts and review of previous dose equivalency tables.

Main Results:

• Introduction of comprehensive dose equivalency tables for key psychotropic drug classes available in Japan.
• Tables are based on Japanese clinical trial data and expert consensus.
• Updated information is accessible online for ongoing reference.

Conclusions:

• The developed dose equivalency tables offer valuable guidance for psychotropic medication management in Japan.
• Physicians should utilize these tables as approximate references, applying clinical discretion.
• These tables support more accurate dose estimations and comparisons within the Japanese context.